MAZE
Maze Therapeutics, Inc. · Healthcare
President, R&D & CMO Harold Bernstein sold $437K of Maze Therapeutics, Inc.
Sold$436,864
$29.90Price
14,609Shares
−100%Stake
What MAZE did after the filing
- The stock from Mon, Jul 6 open, $31.25
- −6.8%
- S&P 500, same days
- +2.5%
Measured over 30 trading days, to the Aug 18 close.
Traded Wed, Jul 1. Filed Thu, Jul 2, 4:29 PM ET, after the close. Returns use the Jul 6 open and the Aug 18 close. Not investment advice.